Search

Search Constraints

You searched for: Author/Creator Wojciechowski, David

Search Results

2. 310.3: Posoleucel as Preemptive Therapy for BKV Infection in Kidney Transplant Recipients: Safety, Tolerability and Efficacy in a Phase 2 Trial. (13th September 2022)

3. 310.3: Posoleucel as Preemptive Therapy for BKV Infection in Kidney Transplant Recipients: Safety, Tolerability and Efficacy in a Phase 2 Trial. (13th September 2022)

4. 336.2: Elevated Donor-Derived Cell-Free DNA (Dd-cfDNA) in the Early Post-transplant Period Is Associated With an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients. (13th September 2022)

5. A Prospective Multi-Center Observational Trial to Evaluate a CMV-specific ELIspot Assay in Solid Organ Transplant (SOT) Recipients: The PROTECT Study. (July 2018)

6. A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients. Issue 9 (15th March 2019)